The distinguishing pathogenic features of neurodegenerative diseases include
mitochondrial dysfunction and derived reactive oxygen species generation. The neural …

Suboptimal sleep causes cognitive decline and probably accelerates Alzheimer's Disease
(AD) progression. Several sleep interventions have been tested in established AD dementia …

Contextual measurements of multiple physiological signals using familiar garments or
accessories can provide insights into health and behavior. Recording these signals on or …

Due to worldwide demographic change, the number of older persons in the population is
increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid …

Dementia is a significant public health crisis; the most common underlying cause of age-
related cognitive decline and dementia is Alzheimer's disease neuropathologic change …

This paper presents radiooculogram (ROG), a novel sensor for non-invasive eye movement
(EM) monitoring with eyes closed. We have experimentally demonstrated accurate …

Treatment with melatonin is routinely prescribed for its potent antioxidant and cognitive‐
promoting effects, nevertheless, it has yet to find neuromodulatory effects in normal and …

Introduction: It has been reported that melatonin diminishes rapid eye movement (REM)
sleep latency in patients with Alzheimer's disease (AD). Pharmacological studies suggest …

Melatonin (MT) from plant species has attracted attention in the past decade. It is still the
only conserved molecule that is broad spectrum as a regulator of biological functions since it …

The most prevalent chronic disease among senior people, and its prevalence rises with age,
is Alzheimer's disease (AD). One study predicts that the prevalence of dementia will triple …